Scaffold hopping approach towards various AFQ-056 analogs as potent metabotropic glutamate receptor 5 negative allosteric modulators.
暂无分享,去创建一个
M. Hechenberger | U. Abel | U. Meyer | Kai-Uwe Klein | Holger Kubas | Sander G A van Assema | P. Plitt | R. Zemribo | Harm W Spexgoor
[1] Yi Jin,et al. Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects , 2013, Drug Metabolism and Disposition.
[2] E. Berry-Kravis,et al. Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond , 2012, Neuropsychopharmacology.
[3] K. A. Emmitte,et al. Recent advances in the design and development of novel negative allosteric modulators of mGlu(5). , 2011, ACS chemical neuroscience.
[4] Daniela Berg,et al. Treatment of Levodopa-Induced Dyskinesias : Results of 2 Randomized Controlled Trials , 2011 .
[5] L. Grégoire,et al. The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in L-Dopa-treated parkinsonian monkeys. , 2011, Parkinsonism & related disorders.
[6] P. Malfertheiner,et al. Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro‐oesophageal reflux disease , 2011, Alimentary pharmacology & therapeutics.
[7] V. Mutel,et al. mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents. , 2011, Current topics in medicinal chemistry.
[8] S. Ferguson,et al. Huntington’s Disease and Group I Metabotropic Glutamate Receptors , 2011, Molecular Neurobiology.
[9] C. Humblet,et al. Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.
[10] J. Tack,et al. A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease , 2009, Gut.
[11] W. Spooren,et al. mGlu5 receptor antagonists and their therapeutic potential , 2008 .
[12] C. Goudet,et al. Allosteric functioning of dimeric class C G‐protein‐coupled receptors , 2005, The FEBS journal.
[13] O. Petroff,et al. Book Review: GABA and Glutamate in the Human Brain , 2002 .
[14] K. Sonogashira,et al. Development of Pd–Cu catalyzed cross-coupling of terminal acetylenes with sp2-carbon halides , 2002 .
[15] G. Seabrook,et al. Mobilisation of intracellular Ca2+ by mGluR5 metabotropic glutamate receptor activation in neonatal rat cultured dorsal root ganglia neurones , 2000, Neuropharmacology.
[16] H. Bestmann,et al. An Improved One-pot Procedure for the Synthesis of Alkynes from Aldehydes , 1996 .